Cancer Pain Management: Opioid Analgesics, Part 2

Position Statement on Opioid Analgesics in Pain Management – 2015 Update

Position Statement on Opioid Analgesics in Pain Management--2015 Update.

Erratum to: Pain Management in Patients with Cancer: Focus on Opioid Analgesics

Cancer pain is generally treated with pharmacological measures, relying on using opioids alone or in combination with adjuvant analgesics. Weak opioids are used for mild-to-moderate pain as monotherapy or in a combination with nonopioids. For patients with moderate-to-severe pain, strong opioids are recommended as initial therapy rather than beginning treatment with weak opioids. Adjunctive the...

Pain Pharmacotherapy: Non-Opioid Analgesics [Argoff]

Links: [1] https://www.opioidrisk.com/node/142 [2] http://aps.confex.com/aps/res2008/webprogram/Session2442.html [3] https://www.opioidrisk.com/taxonomy/term/517 [4] https://www.opioidrisk.com/taxonomy/term/554 [5] https://www.opioidrisk.com/taxonomy/term/548 [6] https://www.opioidrisk.com/taxonomy/term/491 [7] https://www.opioidrisk.com/taxonomy/term/179 [8] https://www.opioidrisk.com/taxonomy...

Opioid Analgesics

Intensive research on the neurobiology of pain over the past two decades has revealed many receptors, ion channels and enzymes with potential as novel targets for development of a new generation of analgesic agents. However, despite large investment in preclinical and clinical development of small molecules and biologics as potential novel pain therapeutics, very few have reached the clinic. He...